We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

21 hedge funds and large institutions have $6.32M invested in ImmuCell in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

0% more funds holding

Funds holding: 21 → 21 (0)

0.06% less ownership

Funds ownership: 21.97% → 21.92% (-0.06%)

16% less capital inflows, than outflows

Capital inflows: $78.5K | Capital outflows: $93.5K

Holders
21
Holders Change
–
Holders Change %
0%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$50.6K
2
Heartland Advisors
Heartland Advisors
Wisconsin
+$12.6K
3
Wells Fargo
Wells Fargo
California
+$6.75K
4
Deutsche Bank
Deutsche Bank
Germany
+$4.73K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.38K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$70.9K
2
NC
Northpointe Capital
Michigan
-$12.2K
3
Walleye Trading
Walleye Trading
New York
-$5.73K
4
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$2.5K
5
UBS Group
UBS Group
Switzerland
-$2.14K

ICCC Hedge Fund Activity: Q2 2016 in Review

21 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2016, worth a combined $6.32M — up 0.52% from $6.29M a quarter earlier.

Fund positioning in ICCC was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 6 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $50.6K. The largest seller was Morgan Stanley, cutting an estimated $70.9K.

  • 21 institutional investors held ImmuCell (ICCC) as of Q2 2016, unchanged from Q1 2016.
  • Funds reported $6.32M of ImmuCell stock for Q2 2016, up 0.52% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q2 2016 and 0 closed out.
  • The largest ImmuCell buyer in Q2 2016 was Renaissance Technologies, an estimated $50.6K added.
  • The largest ImmuCell seller in Q2 2016 was Morgan Stanley, an estimated $70.9K sold.

Based on aggregated 13F filings for Q2 2016.